 |
|
Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights
Kenichi Ikejima, Kazuyoshi Kon, Shunhei Yamashina
Clin Mol Hepatol. 2020;26(4):728-735. Published online 2020 Oct 1 DOI: https://doi.org/10.3350/cmh.2020.0202
|
|
Citations to this article as recorded by
 Letter to the Editor: Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality
Hong‐Xia Li, Zhi‐Qin Xie, Zhao‐Ming Yang, Cai‐Xi Tang
Hepatology.2023; 77(4): E67. CrossRef The beneficial impact of metabolic dysfunction‐associated fatty liver disease on lenvatinib treatment in patients with non‐viral hepatocellular carcinoma
Shigeo Shimose, Atsushi Hiraoka, Andrea Casadei‐Gardini, Tsubasa Tsutsumi, Dan Nakano, Hideki Iwamoto, Fujimasa Tada, Margherita Rimini, Masatoshi Tanaka, Takuji Torimura, Hideya Suga, Hideko Ohama, Valentina Burgio, Takashi Niizeki, Etsuko Moriyama, Hiro
Hepatology Research.2023; 53(2): 104. CrossRef Non-alcoholic fatty liver disease: Definition and subtypes
Seul Ki Han, Soon Koo Baik, Moon Young Kim
Clinical and Molecular Hepatology.2023; 29(Suppl): S5. CrossRef Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
Seung Min Lee, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(1): 171. CrossRef Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease
Xiaoqin Wu, Xiude Fan, Tatsunori Miyata, Adam Kim, Christina K. Cajigas-Du Ross, Semanti Ray, Emily Huang, Moyinoluwa Taiwo, Rakesh Arya, Jianguo Wu, Laura E. Nagy
Annual Review of Pathology: Mechanisms of Disease.2023; 18(1): 411. CrossRef Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease
Georg Semmler, Christian Datz, Michael Trauner
Clinical and Molecular Hepatology.2023; 29(Suppl): S244. CrossRef The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
Hyunwoo Oh, Won Sohn, Yong Kyun Cho
Clinical and Molecular Hepatology.2023; 29(Suppl): S261. CrossRef Non-alcoholic fatty liver disease: the pathologist’s perspective
Wei-Qiang Leow, Anthony Wing-Hung Chan, Paulo Giovanni L. Mendoza, Regina Lo, Kihan Yap, Haeryoung Kim
Clinical and Molecular Hepatology.2023; 29(Suppl): S302. CrossRef Therapeutic targets in alcohol-associated liver disease: progress and challenges
Ayooluwatomiwa Deborah Adekunle, Adeyinka Adejumo, Ashwani K. Singal
Therapeutic Advances in Gastroenterology.2023; 16: 175628482311709. CrossRef Anti-Angiogenic Effects of Natural Compounds in Diet-Associated Hepatic Inflammation
Sara Novi, Vincenzo Vestuto, Pietro Campiglia, Nicola Tecce, Alessia Bertamino, Mario Felice Tecce
Nutrients.2023; 15(12): 2748. CrossRef Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets
Yingzhou Shi, Hang Dong, Shiwei Sun, Xiaoqin Wu, Jiansong Fang, Jianbo Zhao, Junming Han, Zongyue Li, Huixiao Wu, Luna Liu, Wanhong Wu, Yang Tian, Guandou Yuan, Xiude Fan, Chao Xu
Clinical and Molecular Hepatology.2023; 30(1): 80. CrossRef Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver disease
Chan-Young Jung, Geun Woo Ryu, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
Diabetologia.2022; 65(3): 518. CrossRef Red meat consumption, obesity, and the risk of nonalcoholic fatty liver disease among women: Evidence from mediation analysis
Mi Na Kim, Chun-Han Lo, Kathleen E. Corey, Xiao Luo, Lu Long, Xuehong Zhang, Andrew T. Chan, Tracey G. Simon
Clinical Nutrition.2022; 41(2): 356. CrossRef Changes in general and central fatness are associated with hepatocellular carcinoma: A Korean nationwide longitudinal study
Mi Na Kim, Kyungdo Han, Juhwan Yoo, Yeonjung Ha, Young Eun Chon, Ju Ho Lee, Seong Gyu Hwang
International Journal of Cancer.2022; 150(10): 1587. CrossRef Carbohydrate-deficient transferrin is a sensitive marker of alcohol consumption in fatty liver disease
Maki Morinaga, Kazuyoshi Kon, Akira Uchiyama, Hiroo Fukada, Kyoko Fukuhara, Reiko Yaginuma, Eisuke Nakadera, Shunhei Yamashina, Kenichi Ikejima
Hepatology International.2022; 16(2): 348. CrossRef Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis
Seunghwan Shin, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Diagnostics.2022; 12(2): 441. CrossRef Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study
Chan-Young Jung, Hee Byung Koh, Keun Hyung Park, Young Su Joo, Hyung Woo Kim, Sang Hoon Ahn, Jung Tak Park, Seung Up Kim
Diabetes & Metabolism.2022; 48(4): 101344. CrossRef MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Mohammed Eslam, Jacob George, Takuji Torimura
Clinical and Molecular Hepatology.2022; 28(2): 150. CrossRef Exercise reduces the risk of chronic kidney disease in individuals with nonalcoholic fatty liver disease: A nationwide cohort study
Chan-Young Jung, Ho Soo Chun, Minjong Lee, Hee Byung Koh, Keun Hyung Park, Young Su Joo, Hyung Woo Kim, Sang Hoon Ahn, Jung Tak Park, Seung Up Kim
Diabetes & Metabolism.2022; 48(5): 101362. CrossRef Natural History of Alcohol-Associated Liver Disease: Understanding the Changing Landscape of Pathophysiology and Patient Care
Jasmohan S. Bajaj, Laura E. Nagy
Gastroenterology.2022; 163(4): 840. CrossRef Alcohol use patterns and risk of incident cataract surgery: a large scale case–control study in Japan
Kota Fukai, Ryo Terauchi, Yuko Furuya, Kei Sano, Shoko Nakazawa, Noriko Kojimahara, Keika Hoshi, Tadashi Nakano, Akihiro Toyota, Masayuki Tatemichi
Scientific Reports.2022;[Epub] CrossRef Alcohol-Related Liver Disease: An Overview on Pathophysiology, Diagnosis and Therapeutic Perspectives
Yoonji Ha, Inju Jeong, Tae Hyun Kim
Biomedicines.2022; 10(10): 2530. CrossRef Genome-Scale Metabolic Modeling Reveals Sequential Dysregulation of Glutathione Metabolism in Livers from Patients with Alcoholic Hepatitis
Alexandra Manchel, Radhakrishnan Mahadevan, Ramon Bataller, Jan B. Hoek, Rajanikanth Vadigepalli
Metabolites.2022; 12(12): 1157. CrossRef The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma
Tomomi Kogiso, Katsutoshi Tokushige
Cancers.2021; 13(3): 516. CrossRef Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease
Hee Kyung Shin, Jeong Hwan Park, Jung Hwan Yu, Young-Joo Jin, Young Ju Suh, Jin-Woo Lee, Won Kim
Scientific Reports.2021;[Epub] CrossRef Association between Fasting Ketonuria and Advanced Liver Fibrosis in Non-Alcoholic Fatty Liver Disease Patients without Prediabetes and Diabetes Mellitus
Kiyoung Lim, Minkyu Kang, Junggil Park
Nutrients.2021; 13(10): 3400. CrossRef
|